本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lakewood-Amedex Biotherapeutics (Direct Listing)

0.7310
-0.0512-6.55%
盘后:0.7212-0.0098-1.34%19:58 EDT
成交量:16.07万
成交额:12.05万
市值:173.23万
市盈率:-0.24
高:0.7741
开:0.7703
低:0.7303
收:0.7822
52周最高:98.20
52周最低:0.7303
股本:236.97万
流通股本:138.79万
量比:0.09
换手率:11.58%
股息:- -
股息率:- -
每股收益(TTM):-3.1006
每股收益(LYR):-8.3987
净资产收益率:-402.84%
总资产收益率:-139.40%
市净率:0.40
市盈率(LYR):-0.09

数据加载中...

2026/09/29

重要事件披露

Form 8-K - Current report
2026/09/18

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/15

重要事件披露

Form 8-K - Current report
2026/06/23

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/17

重要事件披露

Form 8-K - Current report
2026/05/22

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

SEC问询函

Form CORRESP - Correspondence
2026/05/01

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/29

重要事件披露

Form 8-K - Current report
2026/04/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/03/12

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/05

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/09

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933